Back to search
FDAFDA · Food and drugs·Recall number D-0254-2026

Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.

Published January 14, 2026 · Recall initiated: December 16, 2025

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

What to do

Voluntary: Firm initiated · E-Mail

Recall details

Brand
OXYCODONE AND ACETAMINOPHEN
Manufacturer
SpecGx, LLC
Distributor
Nationwide
UPC
0304060522053
Lot
Lot: 0523J23904, expires: 05/2027; 0523J24426, 0523J24427, expires: 06/2027.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card